ReviewACS omega2025
Biosensor Strategies for Rapid African Swine Fever Virus Detection.
Review in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
African swine fever (ASF) is a lethal, highly contagious disease that severely threatens global pig populations and the pork industry. Conventional diagnostics based on virus isolation, ELISA, or quantitative PCR are accurate but require specialized laboratories and hours to days of turnaround, creating a demand for pen-side alternatives. Biosensors address this need, yet ASF virus (ASFV) devices remain at an early stage, with limited field validation and few standardized protocols. This review analyzed forty-one ASFV biosensors reported between 2014 and 2025, grouping them by biological receptor (antibody, enzyme, or nucleic acid) and by transduction mechanism (optical, mass-based, or electrochemical). Reported limits of detection extend from five copies per microliter for a CRISPR-Cas12a fluorescence assay
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.